Five things to know about GLP
The Food and Drug Administration has approved GLP-1 medications for treating type 2 diabetes and obesity. Some doctors are prescribing these drugs off-label for a variety of addictive disorders. Research is under way on the effectiveness of treating addiction with these medications, and some initial studies have shown promising results.
Until Molly Gales, 59, started taking a GLP-1 medication for weight loss, this internal monologue—some call it food noise, or food addiction , or simply cravings—was incessant.
Revisiting food addiction in the era of GLP
In this review I aim to re-examine the contested concept of 'food addiction' as a disease in the context of emerging GLP-1-based obesity pharmacotherapies, integrating perspectives from neurobiology, societal impacts, and early evidence for their potential application in other substance-use disorders.
Addiction scholar Carolina Haass-Koffler offers insight on how and why these drugs work and their potential for revolutionizing addiction treatment. Ozempic and Wegovy help people lose weight and curb food cravings. But recent research suggests these kinds of GLP-1 drugs may do more than support weight loss.
The Food and Drug Administration has approved GLP-1 medications for treating type 2 diabetes and obesity. Some doctors are prescribing these drugs off-label for a variety of addictive disorders.
GLP-1 medications like Ozempic and Mounjaro are being explored for addiction treatment, quieting cravings beyond food while FDA approval and access remain limited.
Psychiatric effects of GLP1 receptor agonists
Key points GLP-1 drugs can transform the health of people with obesity, quiet " food noise," and may level the weight-loss playing field. Research on the drugs' mental health effects is mixed. Experts worry widespread use could fuel sizeism and eating disorders. Psychologists are helping GLP-1 patients develop healthy behaviors and manage body image, identity, and relationship changes.
Psychotropic effects of GLP
This review summarizes preclinical, clinical, and real-world findings on the use of GLP -1R agonists in depression , anxiety, binge eating disorder (BED), cognitive impairment, dementia, and substance use disorders involving alcohol, nicotine, cocaine, and opioids. Literature emphasizes human studies and translational models.
Understanding GLP-1 Agonists GLP-1 is an incretin hormone primarily known for its role in glucose homeostasis and satiety regulation. It is released from enteroendocrine cells in the gut in response to nutrient intake. It plays a crucial role in the incretin effect, enhancing insulin secretion in a glucose-dependent manner.
More Context About Glp 1 Depression And Food Addiction
See How GLP-1 Works Through Graphics, Pictures, And Charts. This note connects the source idea with the visuals in a simple, reader-friendly way.
GLP-1 programs the neurovascular landscape: Cell Metabolism. It gives the article a little more context before the image collection begins.
How GLP-1 Can Help in Treating Addiction Disorders?. The extra context helps the page feel more useful without forcing the same phrase repeatedly.
